Children 2014, 1(1), 21-30; doi:10.3390/children1010021
Article

Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic

1,2,* email, 3email, 1email, 1email and 1email
Received: 10 February 2014; in revised form: 8 April 2014 / Accepted: 23 April 2014 / Published: 9 May 2014
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Autism is an etiologically heterogeneous developmental disorder for which the range of genetic investigations has expanded considerably over the past decade. Introduction of chromosomal microarray (CMA) to clinical practice has expanded the range of conditions which pediatricians are able to detect. This study reviewed the utilization, yield and cost of genetic investigations in a sample of children with pervasive developmental disorders (PDD) in an Australian metropolitan child development service. Six hundred and ninety eight patients with PDD were identified from the clinic population. One hundred and ten (15.7%) of the clinic population had undergone investigation with chromosomal microarray, 140 (20.0%) with karyotype (KT), and 167 (23.9%) with Fragile X testing (FRGX). Twelve (10.9%) CMA findings were reported, of which seven (6.3%) were felt to be the likely cause of the child’s clinical features. Five (3.5%) KT findings were reported, of which four (2.9%) were felt to be the likely cause of the child’s clinical features. Two patients (1.2%) were identified with Fragile X expansions. One fifth of the clinic’s recent PDD population had undergone testing with CMA. CMA appears to have increased the diagnostic yield of the genetic investigation of autism, in line with internationally reported levels. Number needed to test (NNT) and cost per incremental diagnosis, were also in line with internationally reported levels.
Keywords: chromosomal microarray; autistic disorder; autism; Asperger syndrome; Rett syndrome; childhood disintegrative disorder; pervasive developmental disorder-not otherwise specified
PDF Full-text Download PDF Full-Text [167 KB, uploaded 9 May 2014 15:11 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Mordaunt, D.; Gabbett, M.; Waugh, M.; O'Brien, K.; Heussler, H. Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic. Children 2014, 1, 21-30.

AMA Style

Mordaunt D, Gabbett M, Waugh M, O'Brien K, Heussler H. Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic. Children. 2014; 1(1):21-30.

Chicago/Turabian Style

Mordaunt, Dylan; Gabbett, Michael; Waugh, Melanie; O'Brien, Karen; Heussler, Helen. 2014. "Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic." Children 1, no. 1: 21-30.

Children EISSN 2227-9067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert